PAMELA BRITNELL: Open Payments
NPI 1952356057 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 26 payments from 10 companies in 2025. Trend: 2023 $429 · 2024 $720 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 4 | $172 |
| Novo Nordisk Inc | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| PFIZER INC. | 3 | $53 |
| Lundbeck LLC | 2 | $38 |
| Dexcom, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Amgen Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Corcept Therapeutics | 1 | $19 |
Products named: VOQUEZNA, Wegovy, VYEPTI, PREVNAR 20, Dexcom G6 Transmitter, BREZTRI, CAPLYTA, VRAYLAR.
Industry payments across AL — which companies pay providers there.
